Share
 
Title
Code
Session Type
Venue
Date Time
Co-Facilitators:
Level:
Target Audience:
Seating limit:

During this workshop, participants learn about the new Hepatitis C virus (HCV) drugs and therapeutic regimens which will become available in many African countries in 2016. They learn about the basics of screening, laboratory and clinical assessments for these patients, common drug toxicities and interactions, counselling issues and patient education, and the follow up of patients on HCV curative regimens. HCV and HIV co-infection treatment and patient management issues are explored. Workshop participants gain a greater working knowledge of the clinical management of HCV in the curative treatment era and in the management of those with HIV/HCV co-infection.

12:45
THWS0601
Hepatitis C presentation, diagnosis, and treatment
Michael Smit, Sinai Hospital of Baltimore, United States
Slides
Slides
Slides
Slides
13:00
THWS0602
HIV and HCV co infection update
Jason Edward Farley, Johns Hopkins University, United States
13:15
THWS0603
South African take on Hep C
13:30
THWS0604
Interactive discussion: HCV testing is critical for early diagnosis, and HCV treatment is highly curative
13:50
THWS0605
Interactive discussion: South African perspective